CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines - Product Image

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines

  • ID: 2834720
  • Report
  • Region: Philippines
  • 199 Pages
  • GlobalData
1 of 5
The Philippines’ pharmaceutical market value will increase from $4.3 billion in 2013 to $8 billion by 2020
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines

Summary

The publisher has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Philippines. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Philippines. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by our team of industry experts.

In 2015, Philippines population was approximately at 100.9 million. The government of Philippines has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country’s future growth. To support this industry, the government has improved regulatory guidelines and initiatives to develop the domestic pharmaceutical market. The Philippines pharmaceutical market is the third-largest pharmaceutical market in the Association of Southeast Asian Nations (ASEAN), after Indonesia and Thailand. The Pharmaceutical market was estimated to be worth $3.4 billion in 2015 and expected to reach $4.1 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 3.7% over the 2008-2020 period. The medical device market was valued at $400m in 2008 and is expected to reach approximately $600m by 2020, at a projected CAGR of 8.1%.

These positive trends can primarily be attributed to -
- An increasing elderly population in Philippines, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices
- Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Philippines, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (United Laboratories, Pfizer, GlaxoSmithKline, Novartis, Merck Co.)
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Philippines healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Philippines healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in Philippines healthcare market
READ MORE
Note: Product cover images may vary from those shown
2 of 5
1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Report Guidance

3 Overview of Pharmaceutical and Medical Device Market

3.1 Pharmaceutical Market

3.1.1 Market Overview

3.1.2 Pharmaceutical Exports and Imports

3.1.3 Supply Channels

3.1.4 Market Segments

3.1.5 Overview of Major Disease Areas

3.1.6 Major Players

3.2 Medical Device Market

3.2.1 Market Overview

3.3 Market Drivers and Barriers

3.3.1 Drivers

3.3.2 Barriers

4 Market Access

4.1 Reimbursement and Payer Landscape

4.1.1 Overview of Healthcare System

4.1.2 Reimbursement Process

4.1.3 Overview of Insurance Providers

4.1.4 Patient Share in Healthcare Spending

4.1.5 Price Trends in the Healthcare Sector

4.1.6 Pricing Policies

4.2 Regulatory Landscape

4.2.1 Overview of Regulatory Agencies

4.2.2 Market Authorization Procedure for Pharmaceutical Products

4.2.3 New Medical Device Approval Process

4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing

4.2.5 Exports and Imports

4.2.6 Intellectual Property Rights

4.2.7 Clinical Trial Regulations

4.2.8 Pharmaceutical Advertising Regulations

4.2.9 Pharmacy Regulations

4.2.10 Labeling and Packaging Regulations

5 Country Analysis

5.1 Political Environment

5.1.1 Political Structure

5.1.2 Analysis of Current Political Environment

5.1.3 Healthcare Policy Initiatives

5.2 Economic Landscape

5.3 Economic Indicators

5.3.1 Gross Domestic Product

5.3.2 Gross National Income

5.3.3 Inflation

5.3.4 Currency Exchange Rate

5.3.5 Foreign Direct Investment

5.3.6 Foreign Exchange Reserves

5.3.7 Trade Balance

5.3.8 Fiscal Deficit

5.3.9 General Government Gross Debt

5.3.10 External Debt

5.3.11 Major Industries

5.4 Demographics

5.4.1 Population

5.4.2 Education and Literacy

5.4.3 Employment

5.4.4 Disease Burden

5.5 Healthcare Infrastructure

5.5.1 Healthcare Facilities

5.5.2 Healthcare Parameters

5.5.3 Environmental Health

5.5.4 Healthcare Personnel

5.6 Healthcare Expenditure

5.6.1 Overview

5.6.2 Major Components of Healthcare Spending

5.6.3 Share of Public and Private Sector

5.6.4 Spending in Pharmaceutical R&D

5.7 Trade Associations

5.7.1 Pharmaceutical and Healthcare Association of the Philippines

5.7.2 The Philippine Pharmaceutical Manufacturers Association

5.7.3 The Philippine Pharmacist Association

5.7.4 The Philippine Medical Association

5.8 Trade Fairs

6 Opportunities and Challenges

6.1 Opportunities

6.2 Challenges

7 Appendix

7.1 Abbreviations

7.2 Bibliography

7.3 Research Methodology

7.3.1 Coverage

7.3.2 Secondary Research

7.3.3 Forecasts

7.3.4 Expert Panel

7.4 Disclaimer

1.1 List of Tables

Table 1: Pharmaceutical Market, Philippines, Revenue ($bn), 2008-2015

Table 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2016-2020

Table 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 2008-2014

Table 4: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008

Table 5: Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015

Table 6: Pharmaceutical Market, Pfizer, Late-Stage Pipeline, 2016

Table 7: GlaxoSmithKline, Global, Major Products Revenue ($m) and Annual Growth (%), 2015

Table 8: Pharmaceutical Market, GlaxoSmithKline, Late-Stage Pipeline, 2016

Table 9: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015

Table 10: Pharmaceutical Market, Novartis, Planned Filings, 2014-2018

Table 11: Merck & Co., Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015

Table 12: Pharmaceutical Market, Global, Late-Stage Pipeline, Merck & Co., 2016

Table 13: Membership in PhilHealth, Philippines, Sector Share (%), 2016

Table 14: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2016

Table 15: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008-2015

Table 16: Price of Healthcare Products, Philippines Change in Average Price of Health Sector (%), 2008-2014

Table 17: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2008-2015

Table 18: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2016-2020

Table 19: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008-2015

Table 20: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2016-2020

Table 21: Economic Indicators, Philippines, Gross National Income per Capita ($), 2008-2014

Table 22: Economic Indicators, Philippines, Average Consumer Price Index, 2008-2013

Table 23: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008-2013

Table 24: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 2008-2015

Table 25: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 2008-2014

Table 26: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 2008-2014

Table 27: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 2008-2015

Table 28: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 2008-2015

Table 29: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008-2014

Table 30: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008-2015

Table 31: Economic Indicators, Philippines, External Debt ($bn), 2008-2015

Table 32: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 2012-2013

Table 33: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 2013-2014

Table 34: Demographics, Philippines, Population (million), 2008-2015

Table 35: Demographics, Philippines, Population (million), 2016-2020

Table 36: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008-2015

Table 37: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2016-2020

Table 38: Demographics, Philippines, Population Distribution by Age Group (%), 2008-2015

Table 39: Demographics, Philippines, Population Distribution by Age Group (%), 2016-2020

Table 40: Demographics, Philippines, Births (per 1,000 population), 2008-2014

Table 41: Demographics, Philippines, Mortality (per 1,000 population), 2008-2014

Table 42: Demographics, Philippines, Major Causes of Mortality (‘000), 2013

Table 43: Demographics, Philippines, Infant Mortality (per 1,000 live births), 2008-2015

Table 44: Demographics, Philippines, Immunization Rate (%), 2008-2014

Table 45: Demographics, Philippines, Major Causes of Male Mortality (‘000), 2013

Table 46: Demographics, Philippines, Major Causes of Female Mortality (‘000), 2013

Table 47: Demographics, Philippines, Maternal Mortality (per 1,000 live births), 2008-2014

Table 48: Demographics, Philippines, Gender Ratio (M/F), 2008-2014

Table 49: Demographics, Philippines, Life Expectancy at Birth (years), 2008-2015

Table 50: Demographics, Philippines, Life Expectancy at Birth (years), 2016-2020

Table 51: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008-2014

Table 52: Demographics, Philippines, Unemployment Rate (%), 2008-2015

Table 53: Demographics, Philippines, Major Diseases, Morbidity (‘000), 2013

Table 54: Demographics, Philippines, Major Diseases, DALYs (per 100,000 population), 2009

Table 55: Healthcare Infrastructure, Philippines, Hospitals, 2008-2014

Table 56: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008-2014

Table 57: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009

Table 58: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 population), 2007-2009

Table 59: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 population), 2008-2014

Table 60: Environmental Health, Philippines, CO2 Emissions (million metric tons), 2008-2014

Table 61: Environmental Health, Philippines, PM2.5 (µg/m³), 2008-2014

Table 62: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008-2014

Table 63: Healthcare Personnel, Philippines, Registered Nurses, 2008-2014

Table 64: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008-2014

Table 65: Healthcare Expenditure, Philippines, Share of Major Components (%), 2013

Table 66: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008-2014

Table 67: Healthcare Market, Philippines, Major Trade Fairs, 2016

1.2 List of Figures

Figure 1: Pharmaceutical Market, Philippines, Revenue ($bn), 2008-2015

Figure 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2016-2020

Figure 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 2008-2014

Figure 4: Pharmaceutical Distribution Channel, Philippines, Distribution Share (%), 2008

Figure 5: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008

Figure 6: Healthcare Market, Philippines, Drivers and Barriers, 2016

Figure 7: Healthcare Market, Philippines, Healthcare System, 2016

Figure 8: Healthcare Market, Philippines, Drug Selection Procedure for Philippine National Drug Formulary, 2016

Figure 9: Healthcare Market, Philippines, Reimbursement Process, 2016

Figure 10: Healthcare Market, Philippines, PhilHealth Milestones, 2016

Figure 11: Membership in PhilHealth, Philippines, Sector Share (%), 2016

Figure 12: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2016

Figure 13: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008-2015

Figure 14: Price of Healthcare Products, Philippines, Change in Average Price of Health Sector (%), 2008-2014

Figure 15: Healthcare Market, Philippines, Food and Drug Administration Structure, 2014

Figure 16: Philippines, Healthcare Market, Approval Process of New Drugs and Medical Devices, 2014

Figure 17: Healthcare Market, Philippines, Approval Process of Generic Drugs, 2016

Figure 18: Healthcare Market, Philippines, Bureau of Health Devices and Technology Structure, 2016

Figure 19: Healthcare Market, Philippines, Licensing Process for Manufacture of Pharmaceuticals and Medical Devices, 2016

Figure 20: Healthcare Market, Philippines, Patent Approval Process, 2016

Figure 21: Healthcare Market, Philippines, Trademark Approval Process, 2016

Figure 22: Healthcare Market, Philippines, Clinical Trial Approval Process, 2014

Figure 23: Healthcare Market, Philippines, Procedure for Opening a Retail Pharmacy, 2014

Figure 24: Healthcare Policy Initiatives, Philippines, Major Healthcare Reforms, 1999-2014

Figure 25: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2008-2015

Figure 26: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2016-2020

Figure 27: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008-2015

Figure 28: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2016-2020

Figure 29: Economic Indicators, Philippines, Gross National Income per Capita ($), 2008-2014

Figure 30: Economic Indicators, Philippines, Average Consumer Price Index, 2008-2013

Figure 31: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008-2013

Figure 32: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 2008-2015

Figure 33: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 2008-2014

Figure 34: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 2008-2014

Figure 35: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 2008-2015

Figure 36: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 2008-2015

Figure 37: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008-2014

Figure 38: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008-2015

Figure 39: Economic Indicators, Philippines, External Debt ($bn), 2008-2015

Figure 40: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 2013-2014

Figure 41: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 2013-2014

Figure 42: Demographics, Philippines, Population (million), 2008-2015

Figure 43: Demographics, Philippines, Population (million), 2016-2020

Figure 44: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008-2015

Figure 45: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2016-2020

Figure 46: Demographics, Philippines, Population Distribution by Age Group (%), 2008-2015

Figure 47: Demographics, Philippines, Population Distribution by Age Group (%), 2016-2020

Figure 48: Demographics, Philippines, Births (per 1,000 population), 2008-2014

Figure 49: Demographics, Philippines, Mortality (per 1,000 population), 2008-2014

Figure 50: Demographics, Philippines, Major Causes of Mortality (‘000), 2013

Figure 51: Demographics, Philippines, Infant Mortality (per 1,000 live births), 2008-2015

Figure 52: Demographics, Philippines, Immunization Rate (%), 2008-2014

Figure 53: Demographics, Philippines, Major Causes of Male Mortality (‘000), 2013

Figure 54: Demographics, Philippines, Major Causes of Female Mortality (‘000), 2013

Figure 55: Demographics, Philippines, Maternal Mortality (per 1,000 live births), 2008-2014

Figure 56: Demographics, Philippines, Gender Ratio (M/F), 2008-2014

Figure 57: Demographics, Philippines, Life Expectancy at Birth (years), 2008-2015

Figure 58: Demographics, Philippines, Life Expectancy at Birth (years), 2016-2020

Figure 59: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008-2014

Figure 60: Demographics, Philippines, Unemployment Rate (%), 2008-2015

Figure 61: Demographics, Philippines, Major Diseases, Morbidity (‘000), 2013

Figure 62: Demographics, Philippines, Major Diseases, DALYs (per 100,000 population), 2009

Figure 63: Healthcare Infrastructure, Philippines, Hospitals, 2008-2014

Figure 64: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008-2014

Figure 65: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009

Figure 66: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 population), 2007-2009

Figure 67: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 population), 2008-2014

Figure 68: Environmental Health, Philippines, CO2 Emissions (million metric tons), 2008-2014

Figure 69: Environmental Health, Philippines, PM2.5 (µg/m³), 2008-2014

Figure 70: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008-2014

Figure 71: Healthcare Personnel, Philippines, Registered Nurses, 2008-2014

Figure 72: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008-2014

Figure 73: Healthcare Expenditure, Philippines, Share of Major Components (%), 2013

Figure 74: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008-2014

Figure 75: Healthcare Market, Philippines, Opportunities and Challenges, 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Philippines' Pharmaceutical Market Value to Reach $8 Billion by 2020, says The authors

The Philippines' pharmaceutical market value will increase from $4.3 billion in 2013 to $8 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 9.4%, thanks to the country's high medicine prices, says research and consulting firm The authors.

According to the company's latest report*, the Philippines have the third largest pharma market among the countries in the Association of Southeast Asian Nations (ASEAN), just after Indonesia and Thailand.

Joshua Owide, The authors's Director of Healthcare Industry Dynamics, says: “Although an increasing disease burden, coupled with prevailing high pharmaceutical prices, are providing the necessary investment incentives for the healthcare market in the Philippines, limited access to healthcare facilities and governmental cuts could yet impede further growth in the future.”

Furthermore, public health insurance provider Philippine Health Insurance Corporation does not cover the country's entire population, resulting in the majority of people being unable to afford medicines.

Owide continues: “The government has taken a number of measures to control the high drug prices to very little effect, thanks to the large amount of imported therapies and the demand for costly branded drugs.”

Additionally, high spending to overcome basic economic concerns, such as poverty, dependence on imports and high external debt, have left the Philippines' government with insufficient funds to finance the development of healthcare infrastructure, according to The authors.

*CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines

This report provides information and analysis on the healthcare, regulatory and reimbursement landscape in the Philippines. It identifies key trends in the Philippines' healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and healthcare infrastructure.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by The authors's team of industry experts.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll